search
Back to results

Short 3-week Antibiotic Treatment Versus 6 Weeks in Adults With Septic Arthritis of Native Joint (SHASAR)

Primary Purpose

Septic Arthritis

Status
Recruiting
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Short antibiotics treatment
Sponsored by
Assistance Publique - Hôpitaux de Paris
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Septic Arthritis focused on measuring Septic Arthritis of native joint, short antibiotic treatment, native joint, septic arthritis

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Septic arthritis of native joint defined by: 1) clinical signs (hot and/or swollen and/or tender and painful joint (measured by a visual analogue scale)) and 2) microbiologically confirmed pyogenic arthritis (microorganism cultured in the synovial fluid joint or in the blood with complete bacterial susceptibility)
  • Patients aged of 18 years or older
  • Informed, written consent obtained from the patient
  • Patient having the rights to French social insurance

Exclusion Criteria:

  • Prosthetic joints
  • Septic arthritis in the past 12 months
  • Osteomyelitis
  • Diabetic foot
  • Septic choc
  • Arthritis due to bacteria resistant to available oral antibiotics
  • Arthritis due to the following microorganisms: Mycobacterium, fungi, Brucella, Borrelia, Neisseria gonorrhoeae, Neisseria meningitidis, Nocardia, Mycoplasma spp, Pseudomonas aeruginosa.
  • Glomerular filtration rate < 30ml/min/1,73m2
  • Neutrophils < 500/mm3
  • Difficulties regarding compliance with oral antibiotics
  • Contraindication to oral antibiotics necessary to treat joint infection
  • Pregnancy or lactating woman
  • Curator or guardianship
  • Participation in other interventional research during the study

Sites / Locations

  • Hôpital Avicenne - Service de Maladies InfectieusesRecruiting
  • Hôpital Avicenne - Service de RhumatologieRecruiting
  • Hôpital Pellegrin Bordeaux - Service de RhumatologieRecruiting
  • Hôpital Ambroise Paré - Service de RhumatologieRecruiting
  • Hôpital Cavale Blanche - Service de Maladies InfectieusesRecruiting
  • CHG Pontoise - Centre Hospitalier René Dubos - Service de RhumatologieRecruiting
  • CHU Tours - Hôpital Trousseau - Service de RhumatologieRecruiting
  • Hôpital Antoine Béclère - Service de Maladies InfectieusesRecruiting
  • CHSF - Service de RhumatologieRecruiting
  • Hôpital Henri Mondor - Service de Maladies InfectieusesRecruiting
  • Hôpital Henri Mondor - Service de RhumatologieRecruiting
  • CHU Dijon Bourgogne - Hôpital François Mitterrand -Service de Maladies InfectieusesRecruiting
  • Hôpital Raymond Poincaré - Service de Maladies InfectieusesRecruiting
  • CHU Grenoble Alpes - Hôpital Michallon - Service de Maladies InfectieusesRecruiting
  • Hopital Bicêtre, Service de Maladies Infectieuses et TropicalesRecruiting
  • Hôpital Bicêtre service de rhumatologieRecruiting
  • CHRU Lille - Service de RhumatologieRecruiting
  • CHR Orléans - Service de RhumatologieRecruiting
  • Hôpital Lariboisière Service de RhumatologieRecruiting
  • Hôpital Saint Antoine - Service de RhumatologieRecruiting
  • Hôpital Pitié Salpetrière - Service de Maladies InfectieusesRecruiting
  • Hôpital Pitié Salpetrière - Service de RhumatologieRecruiting
  • Hôpital Cochin - Service de Maladies InfectieusesRecruiting
  • Hôpital Cochin - Service de RhumatologieRecruiting
  • Hôpital Necker - Service de Maladies InfectieusesRecruiting
  • Hôpital Bichat - Service de Maladies InfectieusesRecruiting
  • Hôpital Bichat - Service de RhumatologieRecruiting
  • GH Diaconesse La Croix St Simon - Service de RhumatologieRecruiting
  • Hôpital Tenon - Service de Maladies InfectieusesRecruiting
  • Hôpital Sud Rennes - Service de RhumatologieRecruiting
  • CHU Saint Etienne - Hôpital Nord - Service de Maladies InfectieusesRecruiting
  • CHU Saint Etienne - Hôpital Nord - Service de RhumatologieRecruiting
  • CHRU Strasbourg - Hôpital de Hautepierre - Service de RhumatologieRecruiting
  • CHU Tours - Hôpital Bretonneau - Service de Maladies Infectieuses
  • Hôpitaux de Brabois - Service de Maladies Infectieuses
  • Hôpitaux de Brabois - Service de RhumatologieRecruiting
  • CHU Grenoble Alpes - Hôpital Sud - Service de RhumatologieRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Short antibiotics treatment

Long antibiotics treatment

Arm Description

patients will receive effective antibiotic treatment (IV and oral) for 3 weeks

patients will receive effective antibiotic treatment (IV and oral) for 6 weeks according to standard care

Outcomes

Primary Outcome Measures

Cure at 16 weeks (4 months) after the beginning of the treatment
Cure is defined as absence of clinical signs of joint infection, absence of treatment failure, absence of relapse

Secondary Outcome Measures

Cure at 24 weeks
Cure is defined as absence of clinical signs of joint infection, absence of treatment failure, absence of relapse
Treatment failure and relapse and relapse rates
% of relapse at 6,16,24 weeks
The patient's quality of life
assessed by a quality of life questionnaire on 3,6,16,24 weeks. The EQ-5D-3L descriptive system comprises the following five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 3 levels: no problems, some problems, and extreme problems. The patient is asked to indicate his/her health state by ticking the box next to the most appropriate statement in each of the five dimensions. This decision results into a 1-digit number that expresses the level selected for that dimension. The digits for the five dimensions can be combined into a 5-digit number that describes the patient's health state.
The residual joint pain in the affected joint
The residual joint pain is measured by a numerical scale. 0 means "no pain at all" and 10 "pain as bad as it could be".
hospital length of stay and total treatments costs
To compare cost-effectiveness and cost utility of 3-week vs 6-week antibiotic strategies for patients with arthritis of native joints
joint mobility
joint mobility is assessed by "good mobility, few mobility, no mobility"

Full Information

First Posted
October 10, 2018
Last Updated
June 12, 2023
Sponsor
Assistance Publique - Hôpitaux de Paris
search

1. Study Identification

Unique Protocol Identification Number
NCT03716921
Brief Title
Short 3-week Antibiotic Treatment Versus 6 Weeks in Adults With Septic Arthritis of Native Joint
Acronym
SHASAR
Official Title
Short 3-week Antibiotic Treatment Versus 6 Weeks in Adults With Septic Arthritis of Native Joint: a Randomized, Open Label, Non-inferiority Trial
Study Type
Interventional

2. Study Status

Record Verification Date
June 2023
Overall Recruitment Status
Recruiting
Study Start Date
February 5, 2019 (Actual)
Primary Completion Date
February 2024 (Anticipated)
Study Completion Date
August 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Assistance Publique - Hôpitaux de Paris

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
In France, the incidence of native joint infections is about 10 per 100 000 person-years, most commonly caused by S.aureus followed by b-haemolytic streptococci. French and international antibiotic guidelines, based on expert advice and retrospective studies, recommend intravenous antibiotics for two weeks, then oral for 4 weeks without evident link between intravenous, prolonged oral treatment and cure. Long term exposure to antibiotics increases bacterial resistance, a major problem of public health. Several studies show that serious infectious can be treated safely by a shorter treatment and with oral antibiotics. There is no randomized controlled trial to establish the duration of antibiotics in native joint infections. Moreover, no consensus prevails on the administration route and duration of antimicrobial therapy. Although most clinicians acknowledge the interest of oral antibiotics and shorter treatment duration, randomized controlled trials are necessary to evaluate this practice. The SHASAR project aims to evaluate whether a shorter antibiotic treatment (3 week treatment) is safe and not inferior to the conventional 6 week treatment in native joint infections. If successful, this would represent a major advance in terms of patients' quality of life; decreased rate of health-care-related infections and complications, bacterial resistance and cost.
Detailed Description
This trial is a nationwide, non inferiority, multicenter French randomized, open-label, controlled trial comparing two treatment durations, 3 versus 6 weeks, in septic arthritis of native joints. Patients who fulfill inclusion criteria will be randomized between day0 and day5. Day 0 is the time when effective intravenous antibiotic treatment is started. Effective treatment is defined by active antibiotics on the identified bacteria according to the susceptibility. The randomisation (1:1 ratio) will be stratified on early planned drainage. Follow-up will include 6 visits and will consist in clinical, biological, radiological, health quality of life (EQ-5D-3L score) and adverse events record. After collection, validation of data and population description, analysis will be conducted on the per-protocol population (patients receiving the planned duration of antibiotic +/-3days). This study will not be carried out blind for feasibility reasons. According to statistical considerations (by accounting for 5% of subjects lost to follow-up), the required sample size will be of 350 patients overall.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Septic Arthritis
Keywords
Septic Arthritis of native joint, short antibiotic treatment, native joint, septic arthritis

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
350 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Short antibiotics treatment
Arm Type
Experimental
Arm Description
patients will receive effective antibiotic treatment (IV and oral) for 3 weeks
Arm Title
Long antibiotics treatment
Arm Type
No Intervention
Arm Description
patients will receive effective antibiotic treatment (IV and oral) for 6 weeks according to standard care
Intervention Type
Other
Intervention Name(s)
Short antibiotics treatment
Other Intervention Name(s)
3-week antibiotic treatment
Intervention Description
Patients randomized in this arm will pursue antibiotic administration until visit 3 weeks after D0
Primary Outcome Measure Information:
Title
Cure at 16 weeks (4 months) after the beginning of the treatment
Description
Cure is defined as absence of clinical signs of joint infection, absence of treatment failure, absence of relapse
Time Frame
16 weeks after Day 0
Secondary Outcome Measure Information:
Title
Cure at 24 weeks
Description
Cure is defined as absence of clinical signs of joint infection, absence of treatment failure, absence of relapse
Time Frame
24 weeks after Day 0
Title
Treatment failure and relapse and relapse rates
Description
% of relapse at 6,16,24 weeks
Time Frame
6,16,24 weeks after Day 0
Title
The patient's quality of life
Description
assessed by a quality of life questionnaire on 3,6,16,24 weeks. The EQ-5D-3L descriptive system comprises the following five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 3 levels: no problems, some problems, and extreme problems. The patient is asked to indicate his/her health state by ticking the box next to the most appropriate statement in each of the five dimensions. This decision results into a 1-digit number that expresses the level selected for that dimension. The digits for the five dimensions can be combined into a 5-digit number that describes the patient's health state.
Time Frame
3,6,16,24 weeks after Day 0
Title
The residual joint pain in the affected joint
Description
The residual joint pain is measured by a numerical scale. 0 means "no pain at all" and 10 "pain as bad as it could be".
Time Frame
at 16 and 24 weeks after Day 0
Title
hospital length of stay and total treatments costs
Description
To compare cost-effectiveness and cost utility of 3-week vs 6-week antibiotic strategies for patients with arthritis of native joints
Time Frame
through study completion, an average of 3 years
Title
joint mobility
Description
joint mobility is assessed by "good mobility, few mobility, no mobility"
Time Frame
at 16 and 24 weeks after Day 0

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Septic arthritis of native joint defined by: 1) clinical signs (hot and/or swollen and/or tender and painful joint (measured by a visual analogue scale)) and 2) microbiologically confirmed pyogenic arthritis (microorganism cultured in the synovial fluid joint or in the blood with complete bacterial susceptibility) Patients aged of 18 years or older Informed, written consent obtained from the patient Patient having the rights to French social insurance Exclusion Criteria: Prosthetic joints Septic arthritis in the past 12 months Osteomyelitis Diabetic foot Septic choc Arthritis due to bacteria resistant to available oral antibiotics Arthritis due to the following microorganisms: Mycobacterium, fungi, Brucella, Borrelia, Neisseria gonorrhoeae, Neisseria meningitidis, Nocardia, Mycoplasma spp, Pseudomonas aeruginosa. Glomerular filtration rate < 30ml/min/1,73m2 Neutrophils < 500/mm3 Difficulties regarding compliance with oral antibiotics Contraindication to oral antibiotics necessary to treat joint infection Pregnancy or lactating woman Curator or guardianship Participation in other interventional research during the study
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Lélia ESCAUT, Dr
Phone
01 45 21 74 26
Ext
+33
Email
lelia.escaut@aphp.Fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Lélia ESCAUT, Dr
Organizational Affiliation
AP-HP Hôpital Bicêtre
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hôpital Avicenne - Service de Maladies Infectieuses
City
Bobigny
ZIP/Postal Code
93000
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Olivier BOUCHAUD
Email
olivier.bouchaud@aphp.fr
Facility Name
Hôpital Avicenne - Service de Rhumatologie
City
Bobigny
ZIP/Postal Code
93000
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Marie Christophe BOISSIER, Dr
Email
marie-christophe.boissier@aphp.fr
Facility Name
Hôpital Pellegrin Bordeaux - Service de Rhumatologie
City
Bordeaux
ZIP/Postal Code
33000
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Thierry SCHAEVERBEKE, PhD
Email
thierry.schaeverbeke@chu-bordeaux.fr
Facility Name
Hôpital Ambroise Paré - Service de Rhumatologie
City
Boulogne-Billancourt
ZIP/Postal Code
92104
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Maxime BREBAN, Dr
Email
maxime.breban@aphp.fr
Facility Name
Hôpital Cavale Blanche - Service de Maladies Infectieuses
City
Brest
ZIP/Postal Code
29600
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Séverine ANSART, PhD
Email
severine.ansart@chu-brest.fr
Facility Name
CHG Pontoise - Centre Hospitalier René Dubos - Service de Rhumatologie
City
Cergy-Pontoise
ZIP/Postal Code
95303
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Edouard PERTUISET, Dr
Email
edouard.pertuiset@ch-pontoise.fr
Facility Name
CHU Tours - Hôpital Trousseau - Service de Rhumatologie
City
Chambray-lès-Tours
ZIP/Postal Code
37170
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Isabelle GRIFFOUL-ESPITALIER, PhD
Email
I.GRIFFOUL@chu-tours.fr
Facility Name
Hôpital Antoine Béclère - Service de Maladies Infectieuses
City
Clamart
ZIP/Postal Code
92140
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sophie ABGRALL, Pr
Email
sophie.abgrall@aphp.fr
Facility Name
CHSF - Service de Rhumatologie
City
Corbeil-Essonnes
ZIP/Postal Code
91100
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Pascal HILLIQUIN, PhD
Email
pascal.hilliquin@ch-sud-francilien.fr
Facility Name
Hôpital Henri Mondor - Service de Maladies Infectieuses
City
Créteil
ZIP/Postal Code
94000
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sébastien Gallien, Dr
Email
sebastien.gallien@aphp.fr
Facility Name
Hôpital Henri Mondor - Service de Rhumatologie
City
Créteil
ZIP/Postal Code
94000
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Xavier CHEVALIER, Dr
Email
xavier.chevalier@aphp.fr
Facility Name
CHU Dijon Bourgogne - Hôpital François Mitterrand -Service de Maladies Infectieuses
City
Dijon
ZIP/Postal Code
21079
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Lionel PIROTH, PhD
Email
lionel.piroth@chu-dijon.fr
Facility Name
Hôpital Raymond Poincaré - Service de Maladies Infectieuses
City
Garches
ZIP/Postal Code
92380
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Aurélien DINH, Pr
Email
aurelien.dinh@aphp.fr
Facility Name
CHU Grenoble Alpes - Hôpital Michallon - Service de Maladies Infectieuses
City
La Tronche
ZIP/Postal Code
38700
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Patricia PAVESE, PhD
Email
ppavese@chu-grenoble.fr
Facility Name
Hopital Bicêtre, Service de Maladies Infectieuses et Tropicales
City
Le Kremlin-Bicêtre
ZIP/Postal Code
94270
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Lélia ESCAUT, Dr
Phone
01 45 21 74 26
Ext
+33
Email
lelia.escaut@aphp.fr
Facility Name
Hôpital Bicêtre service de rhumatologie
City
Le Kremlin-Bicêtre
ZIP/Postal Code
94270
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Xavier MARIETTE, Pr
Email
xavier.mariette@aphp.Fr
Facility Name
CHRU Lille - Service de Rhumatologie
City
Lille
ZIP/Postal Code
59037
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
René Marc FLIPO, PhD
Email
rene-marc.flipo@chru-lille.fr
Facility Name
CHR Orléans - Service de Rhumatologie
City
Orléans
ZIP/Postal Code
45100
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Carine SALLIOT, PhD
Email
carine.salliot@chr-orleans.fr
Facility Name
Hôpital Lariboisière Service de Rhumatologie
City
Paris
ZIP/Postal Code
75010
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Pascal RICHETTE, Dr
Email
pascal.richette@aphp.fr
Facility Name
Hôpital Saint Antoine - Service de Rhumatologie
City
Paris
ZIP/Postal Code
75012
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jérémie SELLAM, Dr
Email
jeremie.sellam@aphp.fr
Facility Name
Hôpital Pitié Salpetrière - Service de Maladies Infectieuses
City
Paris
ZIP/Postal Code
75013
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Stéphane JAUREGUIBERRY, Dr
Email
stephane.jaureguiberry@aphp.fr
Facility Name
Hôpital Pitié Salpetrière - Service de Rhumatologie
City
Paris
ZIP/Postal Code
75013
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Bruno FAUTREL, Dr
Email
bruno.fautrel@aphp.fr
Facility Name
Hôpital Cochin - Service de Maladies Infectieuses
City
Paris
ZIP/Postal Code
75014
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Dominique SALMON, Pr
Email
dominique.salmon@aphp.fr
Facility Name
Hôpital Cochin - Service de Rhumatologie
City
Paris
ZIP/Postal Code
75014
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Yannick ALLANORE, Pr
Email
yannick.allanore@aphp.fr
Facility Name
Hôpital Necker - Service de Maladies Infectieuses
City
Paris
ZIP/Postal Code
75015
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Fanny LANTERNIER, Dr
Email
fanny.lanternier@aphp.fr
Facility Name
Hôpital Bichat - Service de Maladies Infectieuses
City
Paris
ZIP/Postal Code
75018
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Xavier LESCURE, Dr
Email
xavier.lescure@aphp.fr
Facility Name
Hôpital Bichat - Service de Rhumatologie
City
Paris
ZIP/Postal Code
75018
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Philippe DIEUDE, Dr
Email
philippe.dieude@aphp.fr
Facility Name
GH Diaconesse La Croix St Simon - Service de Rhumatologie
City
Paris
ZIP/Postal Code
75020
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sophie GODOT, PhD
Email
SGodot@hopital-dcss.org
First Name & Middle Initial & Last Name & Degree
Valérie ZELLER, PhD
Email
vzeller@hopital-dcss.org
Facility Name
Hôpital Tenon - Service de Maladies Infectieuses
City
Paris
ZIP/Postal Code
75020
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ludovic LASSEL, Dr
Email
ludovic.lassel@aphp.fr
Facility Name
Hôpital Sud Rennes - Service de Rhumatologie
City
Rennes
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Olivia BERTHOUD, PhD
Email
Olivia.BERTHOUD@chu-rennes.fr
Facility Name
CHU Saint Etienne - Hôpital Nord - Service de Maladies Infectieuses
City
Saint-Priest-en-Jarez
ZIP/Postal Code
42270
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Marie-France Lutz, PhD
Email
m.france.lutz@chu-st-etienne.fr
Facility Name
CHU Saint Etienne - Hôpital Nord - Service de Rhumatologie
City
Saint-Priest-en-Jarez
ZIP/Postal Code
42270
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Hubert Marotte, PhD
Email
hubert.marotte@chu-st-etienne.fr
Facility Name
CHRU Strasbourg - Hôpital de Hautepierre - Service de Rhumatologie
City
Strasbourg
ZIP/Postal Code
67200
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jacques Eric GOTTENBERG, PhD
Email
jacques-eric.gottenberg@chru-strasbourg.fr
Facility Name
CHU Tours - Hôpital Bretonneau - Service de Maladies Infectieuses
City
Tours
ZIP/Postal Code
37044
Country
France
Individual Site Status
Withdrawn
Facility Name
Hôpitaux de Brabois - Service de Maladies Infectieuses
City
Vandœuvre-lès-Nancy
ZIP/Postal Code
54500
Country
France
Individual Site Status
Withdrawn
Facility Name
Hôpitaux de Brabois - Service de Rhumatologie
City
Vandœuvre-lès-Nancy
ZIP/Postal Code
54500
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Damien LOEUILLE, PhD
Email
d.loeuille@chru-nancy.fr
Facility Name
CHU Grenoble Alpes - Hôpital Sud - Service de Rhumatologie
City
Échirolles
ZIP/Postal Code
38130
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Philippe GAUDIN, PhD
Email
PGaudin@chu-grenoble.fr

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Short 3-week Antibiotic Treatment Versus 6 Weeks in Adults With Septic Arthritis of Native Joint

We'll reach out to this number within 24 hrs